REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

22/04/2020 12:20

RNS Number : 5044K
  
Morgan Stanley Capital Services LLC
  
22 April 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION




 Name of exempt market-maker


  Morgan Stanley Capital Services LLC




 Company dealt in


  ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


  21 APRIL 2020




 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales




 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  262,025


 82.8800 USD


 80.0400 USD




 




 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  27,236


 82.8200 USD


 80.1500 USD




 
 
(b)           Derivatives transactions (other than options transactions)
 




 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 100


 80.3599 USD




 CFD


 LONG


 9,561


 80.3600 USD




 CFD


 LONG


 666


 80.3600 USD




 CFD


 LONG


 260


 80.4700 USD




 CFD


 LONG


 2,500


 80.7115 USD




 CFD


 LONG


 1,200


 80.7371 USD




 CFD


 LONG


 931


 81.0501 USD




 CFD


 LONG


 718


 81.1947 USD




 CFD


 LONG


 148


 81.4388 USD




 CFD


 LONG


 6,062


 81.7585 USD




 CFD


 SHORT


 159,121


 80.3600 USD




 CFD


 SHORT


 56,265


 80.3600 USD




 CFD


 SHORT


 71


 80.3600 USD




 CFD


 SHORT


 8,600


 80.4911 USD




 CFD


 SHORT


 9,561


 80.7974 USD




 CFD


 SHORT


 8,464


 80.8123 USD




 CFD


 SHORT


 5,084


 80.9853 USD




 CFD


 SHORT


 866


 82.2462 USD




 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 




 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 




 
(ii) Exercising
 




 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  




 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 




Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 




 
 




 Date of disclosure


22 APRIL 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 




 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEUUARRRNUSUAR